Literature DB >> 20009501

Prevalence and risk factors of albuminuria in Type 2 diabetes in Bahrain.

R A Al-Salman1, H A Al-Basri, A S Al-Sayyad, H M Hearnshaw.   

Abstract

Microalbuminuria is the earliest sign of diabetic nephropathy, and is a marker of increased diabetic cardiovascular morbidity and mortality. We investigated the prevalence of albuminuria and associated risk factors among Type 2 diabetes (T2DM) patients, who were attending diabetes clinics at primary healthcare facilities in Bahrain. This was a cross-sectional study on 712 adult T2DM Bahraini patients screened for albuminuria using albumin:creatinine ratio test (ACR), in 9 selected primary healthcare centers in Bahrain in the period February-March 2006. Of the 702 participants, 196 (27.9%) were albuminuric. The prevalence of microalbuminuria (ACR>3.4 mg albumin/mmol creatinine) and macroalbuminuria (protein:creatinine ratio >22 mg protein/ mmol creatinine) were 22.0% (no.=155) and 5.8% (no.=41), respectively. Univariate analysis demonstrated significant associations between albuminuria and older age (>65 yr), longer duration of diabetes, high glycated hemoglobin (HbA1c), elevated triglycerides, total- and LDL-cholesterol, systolic (>160 mmHg) and diastolic (>90 mmHg) blood pressure (BP), and retinopathy. Multivariate regression analysis showed that high HbA1c, higher systolic BP, and long duration of diabetes, were significant predictors of albuminuria, while older age, male gender, and higher triglycerides were borderline predictors. Albuminuria in Bahraini T2DM patients was related to poor glycemic control, higher systolic BP, and longer duration of diabetes. Effective preventive and control strategies of those factors should be urgently implemented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009501     DOI: 10.1007/BF03346530

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  Standards of medical care in diabetes--2006.

Authors: 
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

2.  An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

Authors:  A Y T Wu; N C T Kong; F A de Leon; C Y Pan; T Y Tai; V T F Yeung; S J Yoo; A Rouillon; M R Weir
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

3.  Prevalence of microalbuminuria in type 2 diabetic patients in Karachi: Pakistan: a multi-center study.

Authors:  Muhammad Yakoob Ahmedani; Muhammad Zafar Iqbal Hydrie; Azhar Iqbal; Asma Gul; Waheed Baig Mirza; Abdul Basit
Journal:  J Pak Med Assoc       Date:  2005-09       Impact factor: 0.781

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 5.  Long-term complications of diabetes mellitus.

Authors:  D M Nathan
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

6.  Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India.

Authors:  A Varghese; R Deepa; M Rema; V Mohan
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

7.  Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru.

Authors:  V R Collins; G K Dowse; C F Finch; P Z Zimmet; A W Linnane
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

8.  Frequency and determinants of microalbuminuria in mild hypertension: a primary-care-based study.

Authors:  M A Martínez; A Moreno; A Aguirre de Cárcer; R Cabrera; R Rocha; A Torre; A Nevado; T Ramos; J Neri; G Antón; I Miranda; P Fernández; E Rodríguez; A Miquel; J L Martínez; M Rodríguez; C Eisman; J G Puig
Journal:  J Hypertens       Date:  2001-02       Impact factor: 4.844

9.  Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.

Authors:  M A Gall; P Hougaard; K Borch-Johnsen; H H Parving
Journal:  BMJ       Date:  1997-03-15

10.  High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol.

Authors:  F al-Mahroos; P M McKeigue
Journal:  Diabetes Care       Date:  1998-06       Impact factor: 19.112

View more
  6 in total

1.  Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of ACE (I/D) Gene Polymorphism in Type 2 Diabetic Population from Kutch Region.

Authors:  Deepak N Parchwani; Kamlesh M Palandurkar; D Hema Chandan Kumar; Darshan J Patel
Journal:  Indian J Clin Biochem       Date:  2013-11-20

2.  Gender difference in albuminuria and ischemic heart disease in type 2 diabetes.

Authors:  Manouchehr Nakhjavani; Afsaneh Morteza; Yaser Jenab; Azam Ghaneei; Alireza Esteghamati; Maryam Karimi; Alireza Farokhian
Journal:  Clin Med Res       Date:  2011-10-26

3.  Prevalence of microalbuminuria and its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa.

Authors:  Aneesah A AlFehaid
Journal:  J Family Community Med       Date:  2017 Jan-Apr

Review 4.  Diabetes epidemic sweeping the Arab world.

Authors:  Bisher Abuyassin; Ismail Laher
Journal:  World J Diabetes       Date:  2016-04-25

Review 5.  Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries.

Authors:  Abdulrhman Aldukhayel
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jan-Mar

6.  Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP).

Authors:  Subhasish Bose; Andrew S Bomback; Nehal N Mehta; Shu-Cheng Chen; Suying Li; Adam Whaley-Connell; Joseph Benjamin; Peter A McCullough
Journal:  BMC Nephrol       Date:  2012-09-07       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.